Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections
Fabian Kong, Chris Kenyon, Magnus Unemo
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 7, pp. 1561-1568
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Antimicrobial treatment and resistance in sexually transmitted bacterial infections
Jørgen Skov Jensen, Magnus Unemo
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 435-450
Closed Access | Times Cited: 39
Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections
Aniruddha Hazra, Moira McNulty, Maria Pyra, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 18
Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis
Michael W. Traeger, Wendy A. Leyden, Jonathan E. Volk, et al.
JAMA Internal Medicine (2025)
Closed Access | Times Cited: 2
45 years of tetracycline post exposure prophylaxis for STIs and the risk of tetracycline resistance: a systematic review and meta-analysis
Thibaut Vanbaelen, Sheeba Santhini Manoharan-Basil, Chris Kenyon
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
High tetracycline resistance percentages in Neisseria gonorrhoeae in Europe: is doxycycline post-exposure prophylaxis unlikely to reduce the incident gonorrhoea cases?
Magnus Unemo, Michelle Cole, Csaba Ködmön, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100871-100871
Open Access | Times Cited: 10
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus
Daniel R. Dickstein, Collin R. Edwards, Catherine Rowan, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 6, pp. 377-405
Open Access | Times Cited: 7
Sexually transmitted coinfections among at-risk HIV-positive MSM: implications for optimal preemptive treatment
Tzong‐Yow Wu, Kuan‐Yin Lin, Li‐Hsin Su, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Doxycycline PEP can induce doxycycline resistance in Klebsiella pneumoniae in a Galleria mellonella model of PEP
Chris Kenyon, Zina Gestels, Thibaut Vanbaelen, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials
István Szondy, Fanni Adél Meznerics, Kende Lőrincz, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107186-107186
Open Access | Times Cited: 6
IUSTI Europe position statement on use of DoxyPEP: June 2024
Jackie Sherrard, Deniz Gökengin, Andrew Winter, et al.
International Journal of STD & AIDS (2024) Vol. 35, Iss. 13, pp. 1087-1089
Closed Access | Times Cited: 5
Estimating changes in antibiotic consumption in the USA with the introduction of doxycycline post-exposure prophylaxis
Kirstin Roster, Yonatan H. Grad
The Lancet Microbe (2023) Vol. 5, Iss. 1, pp. e9-e9
Open Access | Times Cited: 11
Re-visiting the potential impact of doxycycline post-exposure prophylaxis (doxy-PEP) on the selection of doxycycline resistance in Neisseria commensals
Leah R. Robinson, Caroline J. McDevitt, Molly R. Regan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Acceptability and feasibility of pre-exposure prophylaxis for bacterial STIs: a systematic review
Julie‐Anne Carroll, Amy B. Mullens, Sarah Warzywoda, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317669-e0317669
Open Access
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021–2024—doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdens
Daniel Schröder, Thitima Cherdtrakulkiat, Le Huu Doanh, et al.
Journal of Antimicrobial Chemotherapy (2025)
Closed Access
Revisiting the potential impact of doxycycline post-exposure prophylaxis on the selection of doxycycline resistance in Neisseria commensals
Leah R. Robinson, Caroline J. McDevitt, Molly R. Regan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An overview of potential combinations therapies with ceftriaxone as a treatment for gonorrhea
Izumo Kanesaka, Fabian Kong, Thibaut Vanbaelen, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
Four recent insights suggest the need for more refined methods to assess the resistogenicity of doxycycline post exposure prophylaxis
Thibaut Vanbaelen, Sheeba Santhini Manoharan-Basil, Chris Kenyon
Current Research in Microbial Sciences (2024) Vol. 6, pp. 100234-100234
Open Access | Times Cited: 3
High‐Throughput Shotgun Metagenomics of Microbial Footprints Uncovers a Cocktail of Noxious Antibiotic Resistance Genes in the Winam Gulf of Lake Victoria, Kenya
Sandra Khatiebi, Kelvin Kiprotich, Zedekiah Onyando, et al.
Journal of Tropical Medicine (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Doxcycline post-exposure prophylaxis: are we using the correct method to assess for effect on antimicrobial resistance?
Thibaut Vanbaelen, Zina Gestels, Saïd Abdellati, et al.
(2024)
Open Access | Times Cited: 2
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort
Mark A. M. van den Elshout, Eline Wijstma, Anders Boyd, et al.
PLoS Medicine (2024) Vol. 21, Iss. 5, pp. e1004328-e1004328
Open Access | Times Cited: 2
DOXY do, or DOXY Don’t? Syphilis and doxycycline post-exposure prophylaxis: A case report
Omar Chircop, Courtney Jaggers, Martha Spiteri, et al.
International Journal of STD & AIDS (2024)
Closed Access | Times Cited: 2
Estimating changes in antibiotic consumption with the introduction of doxycycline post-exposure prophylaxis in the United States
Kirstin Roster, Yonatan H. Grad
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Doxycycline Postexposure Prophylaxis for STIs in Women — Uncertain Benefit, Urgent Need
Jeanne Marrazzo
New England Journal of Medicine (2023) Vol. 389, Iss. 25, pp. 2389-2390
Closed Access | Times Cited: 5
Doxycycline-PEP — novel and promising but needs monitoring
Magnus Unemo, Fabian Kong
Nature Reviews Urology (2023) Vol. 20, Iss. 9, pp. 522-523
Closed Access | Times Cited: 4
Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa
Remco P. H. Peters, James McIntyre, Nigel Garrett, et al.
Southern African Journal of HIV Medicine (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top